Michael R. Stillings
Michael R. Stillings publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and biological activity and Organic Chemistry Cycloaddition Reactions.
- World rank
- #2,715,966 of 7,710,434 ranked researchers
- Rank in Netherlands
- #56,577 of 107,149
- Works
- 45
- Citations
- 1.1k
- Citations per work
- 24.4
What does Michael R. Stillings research?
Michael R. Stillings's work is mostly in Chemistry (48%), Biochemistry, Genetics and Molecular Biology (10%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2248.0%
- Chemistry2248.0%
- Everything else1328.5%
- Life Sciences613.3%
- Health Sciences510.2%
- Medicine510.2%
- 1Organic Chemistry45% of their works
- 2Molecular Biology10% of their works
- 3Pharmacology6% of their works
- 4Cardiology and Cardiovascular Medicine5% of their works
- 5Spectroscopy3% of their works
- 6Pharmacology3% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and biological activity
- Organic Chemistry Cycloaddition Reactions
- Synthesis and Reactions of Organic Compounds
- Inflammatory mediators and NSAID effects
- Phenothiazines and Benzothiazines Synthesis and Activities
- Eicosanoids and Hypertension Pharmacology
- Asymmetric Synthesis and Catalysis
Which keywords describe Michael R. Stillings's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Anticancer, Antimicrobial, Inflammation, Biological Evaluation, Triazines and Heterocyclic Compounds.
- Epoxyeicosatrienoic Acids
- Arachidonic Acid
- Biological Activities
- Imidazoles
- Cancer
- Organic Chemistry
- Heterocyclic Compounds
- Biological Evaluation
- Antimicrobial
- Heterocycles
- Synthesis
- Anticancer
- Inflammation
- Triazines
- Medicinal Chemistry
- Reactivity
- Cyclooxygenase-2 Inhibitors
- Oxazolones
- Phenothiazines
- Enantioselective Reactions
- Organocatalysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis193 topics
- Heterocycles142 topics
- Anticancer132 topics
- Antimicrobial132 topics
- Inflammation102 topics
- Biological Evaluation81 topic
- Triazines81 topic
- Heterocyclic Compounds71 topic
- Medicinal Chemistry71 topic
- Organic Chemistry71 topic
- Reactivity71 topic
- Cancer61 topic
- Cyclooxygenase-2 Inhibitors61 topic
- Imidazoles61 topic
- Oxazolones61 topic
- Biological Activities51 topic
- Phenothiazines51 topic
- Arachidonic Acid41 topic
- Enantioselective Reactions41 topic
- Epoxyeicosatrienoic Acids41 topic
- Organocatalysis41 topic
Where does Michael R. Stillings work?
Michael R. Stillings's main affiliation in the publication record is Reckitt Benckiser (Netherlands), Netherlands.
How many publications and citations does Michael R. Stillings have?
OpenAlex counts 45 works and 1,096 citations for Michael R. Stillings, an h-index of 19, ranking #2,715,966 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael R. Stillings. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.